Innate Pharma S.A.
NASDAQ:IPHABiotechnology
Healthcare
$1.03 +1.91%
+$0.03 today
- Market cap
- $115.05M
- Beta
- 0.89
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$0.54
52W Low $1.17High $2.63
Volume 0.50M
Average 0.07M
Price history
Innate Pharma S.A. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-42.46%
Period high
$2.54
Period low
$1.03
Latest
$1.03
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 6-K | Nov 12, 2026 | Nov 12, 2026 | |
| 6-K | Nov 5, 2026 | Nov 5, 2026 | |
| 6-K | Oct 27, 2026 | Oct 27, 2026 | |
| 6-K | Oct 21, 2026 | Oct 21, 2026 | |
| 6-K | Oct 20, 2026 | Oct 20, 2026 | |
| 6-K | Sep 17, 2026 | Sep 17, 2026 | |
| 6-K | Sep 17, 2026 | Sep 17, 2026 | |
| 6-K | Sep 17, 2026 | Sep 17, 2026 | |
| 6-K | Sep 10, 2026 | Sep 10, 2026 | |
| 6-K | Sep 2, 2026 | Sep 2, 2026 | |
| 6-K | Aug 19, 2026 | Aug 19, 2026 | |
| 6-K | Aug 14, 2026 | Aug 14, 2026 | |
| 6-K | Aug 10, 2026 | Aug 10, 2026 | |
| 6-K | Jul 23, 2026 | Jul 23, 2026 | |
| 6-K | Jul 21, 2026 | Jul 21, 2026 |
Competitors
Who does Innate Pharma S.A. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about IPHA's filings, answered from its disclosures.
What is the latest IPHA filing?
The latest filing shown is 6-K dated Nov 12, 2026.
How many recent filings does IPHA have?
Intrinsic Alpha currently shows 20 recent filings for IPHA.
Continue the stock analysis
Jump to another research area for this company.